FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in response to a comment request and presubmission conferences regarding new animal drug applications and supporting regulations, and the use of FDA Form 356V.